Bellast® Plus Dermal Filler for Clinics

This cross-linked hyaluronic acid dermal filler with lidocaine is supplied in a sterile, prefilled 1 mL presentation for professional injection. Clinics use the product for facial contouring and fold refinement within established aesthetic workflows. Your team can align appointment planning and procurement through US distribution.

What Bellast Is and How It Works

Bellast® Plus is a sterile, cross-linked hyaluronic acid injectable gel with integrated lidocaine 0.3%. The HA concentration is 20 mg/mL, providing a balanced, cohesive gel designed for precision placement by trained injectors. As with similar HA fillers, the gel binds water within the soft tissue matrix and gradually degrades through normal metabolic pathways.

This preparation is produced from non-animal hyaluronic acid and cross-linked with BDDE, with low residuals to support product purity. The formulation profile supports smooth extrusion, even distribution, and stable contouring in appropriately selected facial areas. Med Wholesale Supplies serves licensed clinics and healthcare professionals with authentic, brand-name medical products sourced through vetted distributors.

Within your filler portfolio, it functions as a versatile workhorse for mid-to-deep aesthetic corrections at the clinician’s discretion. For category context, see our Dermal Fillers assortment.

Professional Applications

Clinical teams typically position this product for moderate-to-deep facial fold correction and volumizing tasks that benefit from a cohesive, moldable gel. Use cases may include addressing nasolabial and marionette lines, harmonizing chin and jawline contours, and refining nasal or midface definition as permitted by local protocols and practitioner training.

It integrates efficiently into consult-to-procedure workflows where predictable handling and patient comfort are priorities. Practices consolidating a unified filler range can review the family portfolio via our Brand Overview to maintain consistent rheology and technique across sessions.

Key Features

• Cross-linked HA gel: balanced cohesivity for contour control
• Non-animal source: biocompatible and gradually resorbable
• Integrated lidocaine 0.3%: supports in-procedure comfort
• Purity focus: low residual BDDE
• Low endotoxin: under 0.5 EU/mL
• Sterile, single-use: prefilled 1 mL syringe
• Smooth extrusion: consistent injection force
• Predictable handling: steady viscosity across passes

Benefits in Practice

This filler supports confident sculpting and shaping with a gel structure that resists migration under routine forces. Consistent rheology across lots helps teams maintain technique, reduce rework, and standardize expected outcomes during multi-area treatments.

Integrated lidocaine can reduce the need for separate topical steps and streamline chair time. Single-use, sealed packaging fits sterile field protocols and simplifies room turnover between appointments. Inventory teams appreciate the straightforward unit format for forecasting and reordering.

For additional planning insight across this category, clinics can review our concise Filler Guide, which outlines typical filler selection considerations for natural-looking volume work.

Composition & Ingredients

The formulation centers on cross-linked hyaluronic acid in a buffered gel, supported by lidocaine for comfort during injection. This section lists the composition as provided by the manufacturer.

• Active component: hyaluronic acid, cross-linked
• Concentration: 20 mg/mL
• Anesthetic: lidocaine 0.3%
• Cross-linking agent: BDDE (low residual)

In context of class materials, Bellast Plus hyaluronic acid provides the volumizing backbone, while cross-linking modulates cohesivity and longevity within soft tissues. The anesthetic component supports comfort during placement.

Packaging & Supply

This product is supplied as a single, prefilled unit suitable for single-patient use. The pack presentation supports sterile handling in clinical rooms and efficient inventory checks.

• Pack size: 1.0 mL x 1 syringe
• Labeling: visible lot and expiry details
• Unit type: sterile, prefilled syringe
• SKU: 89710

For specification reference, clinics may see the notation Bellast Plus 1 x 1ml in ordering or inventory systems. The labeled concentration (20 mg/mL) and lidocaine content (0.3%) are printed on unit packaging to support verification at intake.

Ordering & Logistics

Licensed accounts can add items to curated lists and finalize orders after credential verification. Sign in to view tier eligibility and any active contract terms aligned to your practice type. Your ordering dashboard supports reorders and packing slip reconciliation for routine restocking.

If you require clarity on lead times or clinic consolidation across branches, our team can outline typical turnaround windows. For forward planning, please reference Bellast Plus US shipping details on your account page or contact support for region-specific guidance.

Comparable Products

Clinics evaluating gel behavior across adjacent platforms may compare this preparation with Revofil Plus for mid-depth volumizing. For a higher-density option with anesthetic, consider Saypha Volume Plus. Practices standardizing within the same family often pair with the lighter variant, accessible here as L Syringe, to broaden indication coverage while maintaining familiar handling.

Pricing & Access

Sign in to view clinic-specific tiers and contract opportunities for recurring schedules. Volume commitments can optimize allocation across treatment days and reduce cart friction for large orders. For procurement teams, Bellast Plus wholesale availability appears once your credentials are validated and the product is added to your authorized catalog.

Availability & Substitutions

Supply can vary by lot and distributor intake. If your required quantity is constrained, your account representative can recommend equivalent class alternatives or staggered fulfillment approaches. For category comparisons that may aid substitution decisions, review our article Revofil vs Juvederm and consult your internal protocols before product changes.

Authoritative Sources

For clinical background on hyaluronic acid fillers and device-class considerations, the following independent resources may be useful:

• FDA: Dermal Fillers (Soft Tissue Fillers)
• MedlinePlus: Cosmetic Injections
• NIH PubChem: Hyaluronic Acid

For a broader view of our device assortment, explore the Medical Devices category.

Ready to add this item to your formulary? Sign in to verify eligibility and place an order with temperature-controlled handling when required and tracked US delivery.